
Enveda Biosciences, a Boulder-based biotech firm, innovatively transforms plant molecules into drugs using advanced AI.
Enveda Biosciences, founded in Boulder, Colorado, is a pioneering biotechnology company focused on transforming plant molecules into novel drugs for challenging diseases. Their core mission is to unlock the vast chemical diversity of nature to discover new medicines. Utilizing cutting-edge technologies such as knowledge graphs, machine learning, and metabolomics, Enveda aims to rapidly explore and harness the untapped potential of natural compounds. Their innovative platform seeks to revolutionize drug discovery by accelerating the identification and development of therapeutic molecules from the natural world.
Notable figures associated with Enveda Biosciences include key scientists and industry experts who contribute to their advanced research and development efforts. The company has attracted significant investment from leading venture capital firms in the biotech sector, underscoring its potential and credibility. Enveda's achievements include the successful identification of promising drug candidates and the establishment of strategic partnerships that enhance their research capabilities. Overall, Enveda Biosciences is making a substantial impact on the pharmaceutical industry by expanding the horizons of drug discovery through nature-inspired innovation.

Locanabio

Locus Fermentation Solutions
locusfs.com

Lykos Therapeutics
lykospbc.com

Arbor Biotechnologies
arbor.bio

Versatope Therapeutics

ApexEdge
apexedge.com

Wayfinder Biosciences
wayfinderbio.com

Iambic Therapeutics
iambic.ai

Artiva Biotherapeutics
artivabio.com

Boundless Bio

BigHat Biosciences
bighatbio.com

CaraVan Biologix
caravanbio.com

Adaptyv Biosystems
adaptyvbio.com

Avanza Laboratories

Regenerative Bio
regen-bio.us
Companies similar to Enveda Biosciences include Locanabio, Locus Fermentation Solutions, Lykos Therapeutics and Arbor Biotechnologies.
Enveda Biosciences was founded in 2019.
Enveda Biosciences' headquarters is located in Boulder, CO, US.
Enveda Biosciences' most recent funding round was for $51M (USD) in April 2023.
As of Apr 20, 2023, Enveda Biosciences has raised a total of $174.9M (USD).
Enveda Biosciences has 175 employees as of Feb 4, 2024.